Skip to content

Justice-Involved Veterans and Moral Reconation Therapy

Improving Treatment Engagement and Outcomes Among Justice-involved Veterans

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT02524171
Acronym
MRT
Enrollment
344
Registered
2015-08-14
Start date
2016-04-04
Completion date
2021-03-30
Last updated
2023-07-27

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Antisocial Personality Disorder, Substance Use Disorder

Keywords

crime, mental health, substance abuse, homelessness, Veterans

Brief summary

The purpose of this study is to determine whether Moral Reconation Therapy (MRT) is effective for reducing risk of criminal recidivism and improving other health-related outcomes (substance use, mental health, housing, and employment problems) among justice-involved Veterans entering residential mental health treatment programs in the Department of Veterans Affairs (VA).

Detailed description

Approximately 146,000 Veterans are released each year from correctional settings; however, two thirds will likely reoffend and return to the justice system. Antisocial cognitions and behaviors are the strongest predictors of reoffending and are highly prevalent among justice-involved Veterans (JIVs). However, in the absence of treatments with demonstrated effectiveness with JIVs, no systematic approach to address antisocial cognitions and behaviors has been implemented in VA. Moral Reconation Therapy (MRT) is a cognitive-behavioral intervention that aims to reduce antisocial cognitions and behaviors. MRT has the best empirical support for reducing risk for criminal recidivism among civilian offenders, and its associated mechanisms (improvements in interpersonal functioning and impulse control) have been linked to improvements in health-related outcomes that are also risk factors for recidivism (substance use, mental health, housing, and employment problems). However, no trials have been conducted with JIVs. Differences between JIVs and justice-involved civilians (e.g., prevalence of traumatic brain injuries; interpersonal problems) suggests prior research on MRT with civilians may not be generalizable, and prompted the VA's Veterans Justice Programs (VJP) and the developers of MRT to develop a Veteran-specific curriculum of this intervention. Using the new Veteran-specific manual, the overarching objective of the current proposal is to implement and evaluate MRT as an intervention to reduce risk for criminal recidivism and improve health-related outcomes among JIVs in VA Mental Health Residential Rehabilitation Treatment Programs (MH RRTPs). Using a Hybrid Type 1 design, this project will test the effectiveness of MRT in a multisite Randomized Controlled Trial (RCT) (Palo Alto, Little Rock, and Bedford VAs) and conduct a formative evaluation to facilitate future implementation of MRT in VA.

Interventions

BEHAVIORALMoral Reconation Therapy (MRT)

MRT is a group-based cognitive-behavioral intervention to restructure antisocial thinking. Patients will receive two groups per week of this intervention for approximately 12 weeks, in addition to the usual care they receive in the mental health residential rehabilitation treatment program.

Sponsors

VA Office of Research and Development
Lead SponsorFED

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
SINGLE (Outcomes Assessor)

Masking description

Research Assistants conducting the 6- and 12- month outcome assessments are blinded to condition assignment.

Eligibility

Sex/Gender
ALL
Healthy volunteers
No

Inclusion criteria

* Veterans who * (a) are entering a mental health residential rehabilitation treatment program (MH RRTP) at one of three study sites (Palo Alto, Little Rock, or Bedford VA), and * (b) had been arrested and charged and/or released from incarceration in the past 5 years prior to MH RRTP admission will be eligible for participation

Exclusion criteria

* The only exclusion criterion is being too cognitively impaired to understand the informed consent process and other study procedures.

Design outcomes

Primary

MeasureTime frameDescription
Risk for Criminal Recidivism (Criminal Thinking)6 months (post-baseline)The Psychological Inventory of Criminal Thinking Styles (56 items) was administered to assess criminal thinking. The measure includes scales of Mollification, Cutoff, Entitlement, Power Orientation, Super-optimism, Cognitive Indolence, and Discontinuity . Scores on these scales were summed to create a General Criminal Thinking score, which has been validated as an overall index of recidivism risk. Higher scores equate to more criminal thinking. Scores were converted to a T-score metric (M=50, SD=10), calculated in reference to norms from samples of incarcerated offenders.

Secondary

MeasureTime frameDescription
Drug Use6 months (post-baseline)The quantity and frequency of patients' self-reported drug use in the past 6 months, measured with the Timeline Follow-Back interview. It was administered at each time point to calculate for the past 6 months total number of days using any drugs (marijuana, cocaine, amphetamines, heroin, other opiates, benzodiazepines, barbiturates, inhalants, or hallucinogens).
Criminal Associates6 months (post-baseline)Scale A of the Measures of Criminal Attitudes and Associates (MCAA; Mills, Kroner, & Forth, 2002) was administered at each interview to quantify participants' associations with criminal peers, a strong predictor of criminal recidivism (Mills, Kroner, & Hemmati, 2004). Participants were asked to consider the four adults (excluding family, co-workers, or other residents in treatment) with whom they spend the most free-time. A count variable was created by summing the number of friends for which the participant answered yes to any of the questions of criminal involvement (possible range=0-4, where a higher score indicates a worse outcome)
Employment Problem Severity6 months (post-baseline)The Employment module of the ASI was administered at each timepoint to assess problem severity in this domain, using composite score indices (range 0 to 1); higher scores indicate greater problem severity.
Alcohol Use6 months (post-baseline)The quantity and frequency of patients' self-reported alcohol use in the past 6 months, measured with the Timeline Follow-Back interview that was administered at the 6-month follow-up interview.
Legal Problem Severity6 months (post-baseline)The Legal Status module of the Addiction Severity Index (ASI; McLellan et al., 2006) was administered at each interview to assess legal problem severity. The latter is based on a composite index derived from five items: Are you presently awaiting charges, trial, or sentence? How many days in the past 30 have you engaged in illegal activities for profit? How serious do you feel your present legal problems are? (0=Not at all, 4=Extremely) How important to you now is counseling or referral for these legal problems? (0=Not at all, 4=Extremely) How much money did you receive from illegal sources in the past 30 days? These items were standardized and aggregated and yield scores ranging from 0 to 1; higher scores indicate greater problem severity of legal problems.
Family/Social Problems6 months (post-baseline)The Family/Social module of the ASI was administered at each timepoint to assess problem severity in this domain, using composite score indices (range 0 to 1); higher scores indicate greater problem severity.
Alcohol Use Problem Severity.6 months (post-baseline)The Alcohol module of the ASI was administered at each time point to assess problem severity in this domain, using composite score indices (ranging from 0 to 1); higher scores indicate greater problem severity. ASI composite scores such as this have long been used to provide internally-consistent evaluations of a patient in a particular problem area (Grahn & Padyab, 2020).

Countries

United States

Participant flow

Recruitment details

Recruitment began on April 4, 2016 from 3 VA Mental Health Residential Rehabilitation Treatment Program (MH RRTP) at Bedford, MA, Little Rock, AR, and Palo Alto, CA. Recruitment officially closed on July 31, 2018.

Pre-assignment details

A total of 344 participants were enrolled across the 3 sites but only 341 were randomized to either the intervention group or control group. Three participants decided to withdraw from the study for various reasons such as declining to finish the baseline interview or deciding that he/she did not want to participate.

Participants by arm

ArmCount
Moral Reconation Therapy (MRT)
MRT is a group-based cognitive-behavioral intervention to restructure antisocial thinking. Patients will receive two groups per week of this intervention for approximately 12 weeks, in addition to the usual care they receive in the mental health residential rehabilitation treatment program. Moral Reconation Therapy (MRT): MRT is a group-based cognitive-behavioral intervention to restructure antisocial thinking. Patients will receive two groups per week of this intervention for approximately 12 weeks, in addition to the usual care they receive in the mental health residential rehabilitation treatment program.
172
Usual Care (UC)
Usual care provided by the mental health residential rehabilitation treatment programs, which patients in both groups are in.
169
Total341

Withdrawals & dropouts

PeriodReasonFG000FG001
12-month Follow-up InterviewLost to Follow-up4541
6-month Follow-upLost to Follow-up5345

Baseline characteristics

CharacteristicTotalMoral Reconation Therapy (MRT)Usual Care (UC)
Age, Categorical
<=18 years
0 Participants0 Participants0 Participants
Age, Categorical
>=65 years
12 Participants6 Participants6 Participants
Age, Categorical
Between 18 and 65 years
329 Participants166 Participants163 Participants
Age, Continuous46.21 years
STANDARD_DEVIATION 12.168
45.83 years
STANDARD_DEVIATION 12.191
46.60 years
STANDARD_DEVIATION 12.169
Controlled environment
Alcohol or drug treatment
265 Participants130 Participants135 Participants
Controlled environment
Jail
27 Participants17 Participants10 Participants
Controlled environment
Medical treatment
8 Participants2 Participants6 Participants
Controlled environment
No
24 Participants14 Participants10 Participants
Controlled environment
Other
5 Participants3 Participants2 Participants
Controlled environment
Psychiatric treatment
12 Participants6 Participants6 Participants
Days in the residential program91.868 Days
STANDARD_DEVIATION 98.183
91.20 Days
STANDARD_DEVIATION 96.035
92.55 Days
STANDARD_DEVIATION 100.326
Race/Ethnicity, Customized
American Indian/Alaska Native
6 Participants4 Participants2 Participants
Race/Ethnicity, Customized
Asian/Pacific Islander
6 Participants4 Participants2 Participants
Race/Ethnicity, Customized
Black or African American
97 Participants45 Participants52 Participants
Race/Ethnicity, Customized
Hispanic or Latino/a, White
16 Participants10 Participants6 Participants
Race/Ethnicity, Customized
Other
19 Participants12 Participants7 Participants
Race/Ethnicity, Customized
White
197 Participants97 Participants100 Participants
Sex: Female, Male
Female
16 Participants8 Participants8 Participants
Sex: Female, Male
Male
325 Participants164 Participants161 Participants
Sites (U.S.)
Continental
110 Participants55 Participants55 Participants
Sites (U.S.)
Northeast
120 Participants61 Participants59 Participants
Sites (U.S.)
Pacific
111 Participants56 Participants55 Participants

Adverse events

Event typeEG000
affected / at risk
EG001
affected / at risk
deaths
Total, all-cause mortality
7 / 17212 / 169
other
Total, other adverse events
0 / 1720 / 169
serious
Total, serious adverse events
2 / 1724 / 169

Outcome results

Primary

Risk for Criminal Recidivism (Criminal Thinking)

The Psychological Inventory of Criminal Thinking Styles (56 items) was administered to assess criminal thinking. The measure includes scales of Mollification, Cutoff, Entitlement, Power Orientation, Super-optimism, Cognitive Indolence, and Discontinuity . Scores on these scales were summed to create a General Criminal Thinking score, which has been validated as an overall index of recidivism risk. Higher scores equate to more criminal thinking. Scores were converted to a T-score metric (M=50, SD=10), calculated in reference to norms from samples of incarcerated offenders.

Time frame: 6 months (post-baseline)

Population: Intent to treat population (all participants assigned to MRT or UC) analyzed using mixed-effects models. Effectiveness was measured by the time x condition interaction term (UC as the reference group).

ArmMeasureValue (MEAN)
Moral Reconation Therapy (MRT)Risk for Criminal Recidivism (Criminal Thinking)53.66 score on a scale
Usual Care (UC)Risk for Criminal Recidivism (Criminal Thinking)53.30 score on a scale
p-value: >0.05Mixed Models Analysis
Comparison: Per protocol analysis, which included all UC participants (n=169) and only those in the MRT condition who had received the minimum recommended dose of the intervention - i.e., Step 3 or higher of MRT (n=63)p-value: >0.05Mixed Models Analysis
Primary

Risk for Criminal Recidivism (Criminal Thinking)

The Psychological Inventory of Criminal Thinking Styles (56 items) was administered to assess criminal thinking. The measure includes scales of Mollification, Cutoff, Entitlement, Power Orientation, Super-optimism, Cognitive Indolence, and Discontinuity . Scores on these scales were summed to create a General Criminal Thinking score, which has been validated as an overall index of recidivism risk. Higher scores equate to more criminal thinking. Scores were converted to a T-score metric (M=50, SD=10), calculated in reference to norms from samples of incarcerated offenders.

Time frame: 12 months (post-baseline)

Population: Intent to treat population (all participants assigned to MRT or UC) analyzed using mixed-effects models. Effectiveness was measured by the time x condition interaction term (UC as the reference group).

ArmMeasureValue (MEAN)
Moral Reconation Therapy (MRT)Risk for Criminal Recidivism (Criminal Thinking)50.96 score on a scale
Usual Care (UC)Risk for Criminal Recidivism (Criminal Thinking)49.80 score on a scale
p-value: >0.05Mixed Models Analysis
Comparison: Per protocol analysis, which included all UC participants (n=169) and only those in the MRT condition who had received the minimum recommended dose of the intervention - i.e., Step 3 or higher of MRT (n=63)p-value: >0.05Mixed Models Analysis
Secondary

Alcohol Use

The quantity and frequency of patients' self-reported alcohol use in the past 6 months, measured with the Timeline Follow-Back interview that was administered at the 6-month follow-up interview.

Time frame: 6 months (post-baseline)

Population: Intent to treat population (all participants assigned to MRT or UC) analyzed using mixed-effects models. Effectiveness was measured by the time x condition interaction term (UC as the reference group).

ArmMeasureValue (MEAN)
Moral Reconation Therapy (MRT)Alcohol Use94 percentage of days abstinent (past 6 mo)
Usual Care (UC)Alcohol Use95 percentage of days abstinent (past 6 mo)
p-value: >0.05Mixed Models Analysis
Comparison: Per protocol analysis, which included all UC participants (n=169) and only those in the MRT condition who had received the minimum recommended dose of the intervention - i.e., Step 3 or higher of MRT (n=63)p-value: >0.05Mixed Models Analysis
Secondary

Alcohol Use

The quantity and frequency of patients' self-reported alcohol use in the past 6 months, measured with the Timeline Follow-Back interview that was administered at the 12-month follow-up interview.

Time frame: 12 months (post-baseline)

Population: Intent to treat population (all participants assigned to MRT or UC) analyzed using mixed-effects models. Effectiveness was measured by the time x condition interaction term (UC as the reference group).

ArmMeasureValue (MEAN)
Moral Reconation Therapy (MRT)Alcohol Use94 percentage of days abstinent (past 6 mo)
Usual Care (UC)Alcohol Use94 percentage of days abstinent (past 6 mo)
p-value: >0.05Mixed Models Analysis
Comparison: Per protocol analysis, which included all UC participants (n=169) and only those in the MRT condition who had received the minimum recommended dose of the intervention - i.e., Step 3 or higher of MRT (n=63)p-value: >0.05Mixed Models Analysis
Secondary

Alcohol Use Problem Severity.

The Alcohol module of the ASI was administered at each time point to assess problem severity in this domain, using composite score indices (ranging from 0 to 1); higher scores indicate greater problem severity. ASI composite scores such as this have long been used to provide internally-consistent evaluations of a patient in a particular problem area (Grahn & Padyab, 2020).

Time frame: 6 months (post-baseline)

Population: Intent to treat population (all participants assigned to MRT or UC) analyzed using mixed-effects models. Effectiveness was measured by the time x condition interaction term (UC as the reference group).

ArmMeasureValue (MEAN)
Moral Reconation Therapy (MRT)Alcohol Use Problem Severity.0.09 score on a scale
Usual Care (UC)Alcohol Use Problem Severity.0.06 score on a scale
p-value: >0.05Mixed Models Analysis
Comparison: Per protocol analysis, which included all UC participants (n=169) and only those in the MRT condition who had received the minimum recommended dose of the intervention - i.e., Step 3 or higher of MRT (n=63)p-value: >0.05Mixed Models Analysis
Secondary

Alcohol Use Problem Severity.

The Alcohol module of the ASI was administered at each time point to assess problem severity in this domain, using composite score indices (ranging from 0 to 1); higher scores indicate greater problem severity. ASI composite scores such as this have long been used to provide internally-consistent evaluations of a patient in a particular problem area (Grahn & Padyab, 2020).

Time frame: 12 months (post-baseline)

Population: Intent to treat population (all participants assigned to MRT or UC) analyzed using mixed-effects models. Effectiveness was measured by the time x condition interaction term (UC as the reference group).

ArmMeasureValue (MEAN)
Moral Reconation Therapy (MRT)Alcohol Use Problem Severity.0.04 score on a scale
Usual Care (UC)Alcohol Use Problem Severity.0.06 score on a scale
p-value: >0.05Mixed Models Analysis
Comparison: Per protocol analysis, which included all UC participants (n=169) and only those in the MRT condition who had received the minimum recommended dose of the intervention - i.e., Step 3 or higher of MRT (n=63).p-value: <0.05Mixed Models Analysis
Secondary

Criminal Associates

Scale A of the Measures of Criminal Attitudes and Associates (MCAA; Mills, Kroner, & Forth, 2002) was administered at each interview to quantify participants' associations with criminal peers, a strong predictor of criminal recidivism (Mills, Kroner, & Hemmati, 2004). Participants were asked to consider the four adults (excluding family, co-workers, or other residents in treatment) with whom they spend the most free-time. A count variable was created by summing the number of friends for which the participant answered yes to any of the questions of criminal involvement (possible range=0-4, where a higher score indicates a worse outcome)

Time frame: 12 months (post-baseline)

Population: Intent to treat population (all participants assigned to MRT or UC) analyzed using mixed-effects models. Effectiveness was measured by the time x condition interaction term (UC as the reference group).

ArmMeasureValue (MEAN)
Moral Reconation Therapy (MRT)Criminal Associates0.37 friends with criminal involvement
Usual Care (UC)Criminal Associates0.43 friends with criminal involvement
p-value: >0.05Mixed Models Analysis
Comparison: Per protocol analysis, which included all UC participants (n=169) and only those in the MRT condition who had received the minimum recommended dose of the intervention - i.e., Step 3 or higher of MRT (n=63).p-value: <0.01Mixed Models Analysis
Secondary

Criminal Associates

Scale A of the Measures of Criminal Attitudes and Associates (MCAA; Mills, Kroner, & Forth, 2002) was administered at each interview to quantify participants' associations with criminal peers, a strong predictor of criminal recidivism (Mills, Kroner, & Hemmati, 2004). Participants were asked to consider the four adults (excluding family, co-workers, or other residents in treatment) with whom they spend the most free-time. A count variable was created by summing the number of friends for which the participant answered yes to any of the questions of criminal involvement (possible range=0-4, where a higher score indicates a worse outcome)

Time frame: 6 months (post-baseline)

Population: Intent to treat population (all participants assigned to MRT or UC) analyzed using mixed-effects models. Effectiveness was measured by the time x condition interaction term (UC as the reference group).

ArmMeasureValue (MEAN)
Moral Reconation Therapy (MRT)Criminal Associates0.43 friends with criminal involvement
Usual Care (UC)Criminal Associates0.28 friends with criminal involvement
p-value: >0.05Mixed Models Analysis
Comparison: Per protocol analysis, which included all UC participants (n=169) and only those in the MRT condition who had received the minimum recommended dose of the intervention - i.e., Step 3 or higher of MRT (n=63)p-value: >0.05Mixed Models Analysis
Secondary

Drug Use

The quantity and frequency of patients' self-reported drug use in the past 6 months, measured with the Timeline Follow-Back interview. It was administered at each time point to calculate for the past 6 months total number of days using any drugs (marijuana, cocaine, amphetamines, heroin, other opiates, benzodiazepines, barbiturates, inhalants, or hallucinogens).

Time frame: 12 months (post-baseline)

Population: Intent to treat population (all participants assigned to MRT or UC) analyzed using mixed-effects models. Effectiveness was measured by the time x condition interaction term (UC as the reference group).

ArmMeasureValue (MEAN)
Moral Reconation Therapy (MRT)Drug Use18.63 Days (in past 6 months)
Usual Care (UC)Drug Use15.03 Days (in past 6 months)
p-value: >0.05Mixed Models Analysis
Comparison: Per protocol analysis, which included all UC participants (n=169) and only those in the MRT condition who had received the minimum recommended dose of the intervention - i.e., Step 3 or higher of MRT (n=63p-value: >0.05Mixed Models Analysis
Secondary

Drug Use

The quantity and frequency of patients' self-reported drug use in the past 6 months, measured with the Timeline Follow-Back interview. It was administered at each time point to calculate for the past 6 months total number of days using any drugs (marijuana, cocaine, amphetamines, heroin, other opiates, benzodiazepines, barbiturates, inhalants, or hallucinogens).

Time frame: 6 months (post-baseline)

Population: Intent to treat population (all participants assigned to MRT or UC) analyzed using mixed-effects models. Effectiveness was measured by the time x condition interaction term (UC as the reference group).

ArmMeasureValue (MEAN)
Moral Reconation Therapy (MRT)Drug Use23.07 Days (in past 6 months)
Usual Care (UC)Drug Use15.01 Days (in past 6 months)
p-value: >0.05Mixed Models Analysis
Comparison: Per protocol analysis, which included all UC participants (n=169) and only those in the MRT condition who had received the minimum recommended dose of the intervention - i.e., Step 3 or higher of MRT (n=63)p-value: >0.05Mixed Models Analysis
Secondary

Employment Problem Severity

The Employment module of the ASI was administered at each timepoint to assess problem severity in this domain, using composite score indices (range 0 to 1); higher scores indicate greater problem severity.

Time frame: 6 months (post-baseline)

Population: Intent to treat population (all participants assigned to MRT or UC) analyzed using mixed-effects models. Effectiveness was measured by the time x condition interaction term (UC as the reference group).

ArmMeasureValue (MEAN)
Moral Reconation Therapy (MRT)Employment Problem Severity0.58 score on a scale
Usual Care (UC)Employment Problem Severity0.61 score on a scale
p-value: >0.05Mixed Models Analysis
Comparison: Per protocol analysis, which included all UC participants (n=169) and only those in the MRT condition who had received the minimum recommended dose of the intervention - i.e., Step 3 or higher of MRT (n=63).p-value: >0.05Mixed Models Analysis
Secondary

Employment Problem Severity

The Employment module of the ASI was administered at each timepoint to assess problem severity in this domain, using composite score indices (range 0 to 1); higher scores indicate greater problem severity.

Time frame: 12 months (post-baseline)

Population: Intent to treat population (all participants assigned to MRT or UC) analyzed using mixed-effects models. Effectiveness was measured by the time x condition interaction term (UC as the reference group).

ArmMeasureValue (MEAN)
Moral Reconation Therapy (MRT)Employment Problem Severity0.48 score on a scale
Usual Care (UC)Employment Problem Severity0.53 score on a scale
p-value: >0.05Mixed Models Analysis
Comparison: Per protocol analysis, which included all UC participants (n=169) and only those in the MRT condition who had received the minimum recommended dose of the intervention - i.e., Step 3 or higher of MRT (n=63).p-value: >0.05Mixed Models Analysis
Secondary

Family/Social Problems

The Family/Social module of the ASI was administered at each timepoint to assess problem severity in this domain, using composite score indices (range 0 to 1); higher scores indicate greater problem severity.

Time frame: 12 months (post-baseline)

Population: Intent to treat population (all participants assigned to MRT or UC) analyzed using mixed-effects models. Effectiveness was measured by the time x condition interaction term (UC as the reference group).

ArmMeasureValue (MEAN)
Moral Reconation Therapy (MRT)Family/Social Problems0.19 score on a scale
Usual Care (UC)Family/Social Problems0.11 score on a scale
p-value: <0.05Mixed Models Analysis
Comparison: Per protocol analysis, which included all UC participants (n=169) and only those in the MRT condition who had received the minimum recommended dose of the intervention - i.e., Step 3 or higher of MRT (n=63).p-value: >0.05Mixed Models Analysis
Secondary

Family/Social Problems

The Family/Social module of the ASI was administered at each timepoint to assess problem severity in this domain, using composite score indices (range 0 to 1); higher scores indicate greater problem severity.

Time frame: 6 months (post-baseline)

Population: Intent to treat population (all participants assigned to MRT or UC) analyzed using mixed-effects models. Effectiveness was measured by the time x condition interaction term (UC as the reference group).

ArmMeasureValue (MEAN)
Moral Reconation Therapy (MRT)Family/Social Problems0.1 score on a scale
Usual Care (UC)Family/Social Problems0.1 score on a scale
p-value: <0.05Mixed Models Analysis
Comparison: Per protocol analysis, which included all UC participants (n=169) and only those in the MRT condition who had received the minimum recommended dose of the intervention - i.e., Step 3 or higher of MRT (n=63)p-value: >0.05Mixed Models Analysis
Secondary

Legal Problem Severity

The Legal Status module of the Addiction Severity Index (ASI; McLellan et al., 2006) was administered at each interview to assess legal problem severity. The latter is based on a composite index derived from five items: Are you presently awaiting charges, trial, or sentence? How many days in the past 30 have you engaged in illegal activities for profit? How serious do you feel your present legal problems are? (0=Not at all, 4=Extremely) How important to you now is counseling or referral for these legal problems? (0=Not at all, 4=Extremely) How much money did you receive from illegal sources in the past 30 days? These items were standardized and aggregated and yield scores ranging from 0 to 1; higher scores indicate greater problem severity of legal problems.

Time frame: 12 months (post-baseline)

Population: Intent to treat population (all participants assigned to MRT or UC) analyzed using mixed-effects models. Effectiveness was measured by the time x condition interaction term (UC as the reference group).

ArmMeasureValue (MEAN)
Moral Reconation Therapy (MRT)Legal Problem Severity0.09 score on a scale
Usual Care (UC)Legal Problem Severity0.09 score on a scale
p-value: >0.05Mixed Models Analysis
Comparison: Per protocol analysis, which included all UC participants (n=169) and only those in the MRT condition who had received the minimum recommended dose of the intervention - i.e., Step 3 or higher of MRT (n=63).p-value: <0.05Mixed Models Analysis
Secondary

Legal Problem Severity

The Legal Status module of the Addiction Severity Index (ASI; McLellan et al., 2006) was administered at each interview to assess legal problem severity. The latter is based on a composite index derived from five items: Are you presently awaiting charges, trial, or sentence? How many days in the past 30 have you engaged in illegal activities for profit? How serious do you feel your present legal problems are? (0=Not at all, 4=Extremely) How important to you now is counseling or referral for these legal problems? (0=Not at all, 4=Extremely) How much money did you receive from illegal sources in the past 30 days? These items were standardized and aggregated and yield scores ranging from 0 to 1; higher scores indicate greater problem severity of legal problems.

Time frame: 6 months (post-baseline)

Population: Intent to treat population (all participants assigned to MRT or UC) analyzed using mixed-effects models. Effectiveness was measured by the time x condition interaction term (UC as the reference group).

ArmMeasureValue (MEAN)
Moral Reconation Therapy (MRT)Legal Problem Severity0.14 score on a scale
Usual Care (UC)Legal Problem Severity0.13 score on a scale
p-value: >0.05Mixed Models Analysis
Comparison: Per protocol analysis, which included all UC participants (n=169) and only those in the MRT condition who had received the minimum recommended dose of the intervention - i.e., Step 3 or higher of MRT (n=63)p-value: <0.05Mixed Models Analysis

Source: ClinicalTrials.gov · Data processed: Mar 7, 2026